Back to Search
IGOR MATUSHANSKY, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1609085679IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
228135(NY)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
228135(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 2001
Research & Publications (14)
MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.
PMID 19671033·Expert Rev Anticancer Ther·2009
6-review
A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.
PMID 18310505·Am J Pathol·2008
8-other
A context dependent role for Wnt signaling in tumorigenesis and stem cells.
PMID 18239459·Cell Cycle·2008
6-review
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.
PMID 17948129·J Clin Invest·2007
7-preclinical
CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells.
PMID 12833137·Oncogene·2003
7-preclinical
Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1.
PMID 11114185·Proc Natl Acad Sci U S A·2000
7-preclinical
Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors.
PMID 11023509·Blood·2000
4-observational
Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell division.
PMID 10762597·Front Biosci·2000
6-review
Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
PMID 19008039·Cancer Lett·2009
6-review
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
PMID 17496901·Nat Med·2007
7-preclinical
PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
PMID 14559995·Mol Cell Biol·2003
7-preclinical
Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
PMID 14559825·Cancer Res·2003
7-preclinical
Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
PMID 11023508·Blood·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 161 FORT WASHINGTON AVENUE, HIP-8
NEW YORK, NY 10032 - Phone
- (646) 317-6041
Quick Facts
- NPI
- 1609085679
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 25
- Publications
- 14
Are you this provider?
Claim Your Profile